357 related articles for article (PubMed ID: 30367831)
21. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
Liang Y; Liu Y; Zhang Q; Zhang H; Du J
Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
[TBL] [Abstract][Full Text] [Related]
23. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
[TBL] [Abstract][Full Text] [Related]
25. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
[TBL] [Abstract][Full Text] [Related]
26. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
[TBL] [Abstract][Full Text] [Related]
27. AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer.
Spirina LV; Avgustinovich AV; Afanas'ev SG; Kondakova IV; Volkov MY; Dobrodeev AY; Boronkina AI
Bull Exp Biol Med; 2020 Nov; 170(1):75-78. PubMed ID: 33231797
[TBL] [Abstract][Full Text] [Related]
28. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Dong P; Xiong Y; Yu J; Chen L; Tao T; Yi S; Hanley SJB; Yue J; Watari H; Sakuragi N
Oncogene; 2018 Sep; 37(39):5257-5268. PubMed ID: 29855617
[TBL] [Abstract][Full Text] [Related]
29. Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer.
He PX; Ma ZL; Han H; Zhang XY; Niu SH; Du LN; Zheng YC; Liu HM
Life Sci; 2020 Feb; 242():117247. PubMed ID: 31899223
[TBL] [Abstract][Full Text] [Related]
30. [Conditional medium of gastric cancer mesenchymal stem cells promotes PD-L1 expression in gastric cancer cells and tumor growth via upregulating VGLL4].
Ding Y; Zhu W; Wang Q; Chen B; Wang M; Zhao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):321-327. PubMed ID: 35583061
[TBL] [Abstract][Full Text] [Related]
31. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.
Qiu XY; Hu DX; Chen WQ; Chen RQ; Qian SR; Li CY; Li YJ; Xiong XX; Liu D; Pan F; Yu SB; Chen XQ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1754-1769. PubMed ID: 29510196
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
Han TS; Voon DC; Oshima H; Nakayama M; Echizen K; Sakai E; Yong ZWE; Murakami K; Yu L; Minamoto T; Ock CY; Jenkins BJ; Kim SJ; Yang HK; Oshima M
Gastroenterology; 2019 Mar; 156(4):1140-1155.e4. PubMed ID: 30508510
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NF-κB is required for oleanolic acid to downregulate PD-L1 by promoting DNA demethylation in gastric cancer cells.
Lu X; Li Y; Yang W; Tao M; Dai Y; Xu J; Xu Q
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22621. PubMed ID: 32894642
[TBL] [Abstract][Full Text] [Related]
35. miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1.
Chen KB; Yang W; Xuan Y; Lin AJ
Cell Death Dis; 2021 Jul; 12(8):748. PubMed ID: 34321456
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.
Qu F; Cao P
Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
[TBL] [Abstract][Full Text] [Related]
37. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Chen J; Jiang CC; Jin L; Zhang XD
Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
[TBL] [Abstract][Full Text] [Related]
38. miR-106b Promotes Metastasis of Early Gastric Cancer by Targeting ALEX1 in Vitro and in Vivo.
Zhu Z; Yang Q; Zhang B; Wu W; Yuan F; Zhu Z
Cell Physiol Biochem; 2019; 52(3):606-616. PubMed ID: 30907988
[TBL] [Abstract][Full Text] [Related]
39. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
Wang J; Liu L; Sun Y; Xue Y; Qu J; Pan S; Li H; Qu H; Wang J; Zhang J
Biomed Pharmacother; 2018 May; 101():406-413. PubMed ID: 29501762
[TBL] [Abstract][Full Text] [Related]
40. Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1.
Liu W; Chen H; Wang D
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):443-451. PubMed ID: 34124983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
